Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by VerusSemperSorson Nov 28, 2021 9:03am
192 Views
Post# 34173278

RE:Question

RE:Question
Camphikefish wrote: Question for all the wise and experienced pharma and biotech investors who have much more insight than I do . I looked back at the original statement from Theralase pointing out Tld-1433 killed 99.99 % of the type 2 Covid strain and had yet to be tested against the type 3 strain we are exposed to at this time . Perhaps there is a new variant which makes this an irrelavant point however , if Tld-1433 is successful at destroying the type 3 virus at the same rate , does big pharma ( and the market ) have an appetite for such an effective treatment ? Given the profits yet to be realized from booster after booster , will there be an effort to possibly capture and bury this technology due to its possible overwhelming efficacy against COVID-19 ? Perhaps it is a silly question and if so , so be it . Like others , I continue to be completely confused as to why this technology / company has not gained share price momentum . If it's half as good as lab results suggest in vitro against cancers and viruses how on earth are we still floundering at such low levels ? Hence the genesis of my question . Does the profit driven mindset of big pharma and other influencers have a desire and a need for such a wonder compound which could potentially be a one and done treatment ? This keeps me awake at night even after all these years ! I'm puzzled . Seems like we should be above $5.00 by now easily but I must be missing something obviously . 


<< Previous
Bullboard Posts
Next >>